SCHEMBL14097676

SCHEMBL14097676

CCOC(=O)Nc1nc2cc(-c3ccccc3)ccc2o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ NPC1 O15118 2/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ TP53 P04637 1/20 0.58
▸ RAF1 P04049 2/20 0.52
▸ BRAF P15056 1/20 0.52
▸ GAA P10253 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ AGPAT2 O15120 2/20 0.49
▸ CETP P11597 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ GLA P06280 1/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097679 0.82 ABL1 (0.59) SMN1; SMN2NPC1RAB9ATP53GAA
SCHEMBL3021481 0.80 RAF1 (0.67) SMN1; SMN2NPC1RAB9ATP53RAF1
SCHEMBL14395652 0.80 GAA (0.48) SMN1; SMN2NPC1RAB9ATP53GAA
SCHEMBL12596881 0.77 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ATP53GAA
SCHEMBL14097700 0.77 GAA (0.50) SMN1; SMN2NPC1RAB9AGAAL3MBTL1
SCHEMBL1467043 0.76 RAF1 (0.86) SMN1; SMN2NPC1RAB9ATP53RAF1
SCHEMBL12162598 0.75 GAA (0.52) SMN1; SMN2NPC1RAB9AGAAL3MBTL1
SCHEMBL14097365 0.74 HDAC6 (0.49) SMN1; SMN2NPC1RAB9APOLBKDM4E
SCHEMBL14097360 0.74 ABL1 (0.57) SMN1; SMN2POLBKDM4EGLAHTT
SCHEMBL5390780 0.72 GAA (0.52) SMN1; SMN2NPC1RAB9AGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback